Your browser doesn't support javascript.
loading
Double Trouble: Dual Antiplatelet Therapy Duration Dilemma in Chronic Kidney Disease Patients With High Bleeding Risk.
Paul, Timir K.
Affiliation
  • Paul TK; Department of Cardiovascular Sciences, University of Tennessee Health Sciences Center at Nashville, Ascension St. Thomas Hospital, Nashville, Tennessee. Electronic address: timirpaul@gmail.com.
Am J Cardiol ; 226: 137-139, 2024 Sep 01.
Article in En | MEDLINE | ID: mdl-38996896
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Renal Insufficiency, Chronic / Hemorrhage Limits: Humans Language: En Journal: Am J Cardiol Year: 2024 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Renal Insufficiency, Chronic / Hemorrhage Limits: Humans Language: En Journal: Am J Cardiol Year: 2024 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA